- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Detailed balance.
Displaying page 1 of 1.
EudraCT Number: 2014-001545-25 | Sponsor Protocol Number: CHDR1409 | Start Date*: 2014-07-02 | ||||||||||||||||
Sponsor Name:Centre for Human Drug Research | ||||||||||||||||||
Full Title: Randomized, double-blind, placebo-controlled, three way crossover, double dummy, single centre study evaluating the effect of haloperidol 2 mg and lorazepam 1 mg on posturography and underlying sys... | ||||||||||||||||||
Medical condition: Healthy volunteers (balance disorders) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001007-38 | Sponsor Protocol Number: VITAMIN E VEDROP/06/LONGTERM/FR | Start Date*: 2007-04-25 |
Sponsor Name:ORPHAN | ||
Full Title: STUDY OF THE LONG TERM BIOLOGICAL EFFICACY AND TOLERABILITY OF VEDROP (VITAMIN E-TPGS FORMULATION) AFTER DAILY ORAL ADMINISTRATION IN 30 PAEDIATRIC PATIENTS WITH CYSTIC FIBROSIS | ||
Medical condition: Paediatric patient who present a cystic fibrosis | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004502-42 | Sponsor Protocol Number: UoL001145 | Start Date*: 2016-03-03 | |||||||||||
Sponsor Name:University of Liverpool | |||||||||||||
Full Title: SATURN: An exploration of the dynamic interaction between IL-17, IL-17 inhibition with (secukinumab) and neutrophils in psoriatic arthritis in vitro and ex vivo with exploratory study on the potent... | |||||||||||||
Medical condition: Psoriatic Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002632-75 | Sponsor Protocol Number: CLI-050000-04 | Start Date*: 2020-07-08 |
Sponsor Name:CHIESI FARMACEUTICI S.p.A | ||
Full Title: Multicenter, open-label, randomised trial to assess the efficacy and tolerability of poractant alfa (porcine surfactant, Curosurf®) in hospitalized patients with SARS-COV-19 acute respiratory distr... | ||
Medical condition: patients with SARS-COV-19 acute respiratory distress syndrome (ARDS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-001148-37 | Sponsor Protocol Number: 200182 | Start Date*: 2018-05-25 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A randomized, double-blind (sponsor unblind), placebo-controlled, multi-centered phase IIa study to evaluate the safety and efficacy of 13 weeks of once daily oral dosing of the selective androgen ... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001785-14 | Sponsor Protocol Number: STRESS-L | Start Date*: 2017-11-09 | ||||||||||||||||
Sponsor Name:University Hospitals Birmingham NHS Foundation Trust | ||||||||||||||||||
Full Title: STRESS-L: STudy into the REversal of Septic Shock with Landiolol (Beta Blockade) | ||||||||||||||||||
Medical condition: Tachycardia in Septic Shock | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003136-23 | Sponsor Protocol Number: CRO1990 | Start Date*: 2012-11-27 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||||||||||||||||||||||
Full Title: Lamotrigine And Borderline Personality Disorder: Investigating Long-Term Effectiveness | ||||||||||||||||||||||||||||||||||||||
Medical condition: Borderline Personality Disorder | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
